TELA Bio to Report Fourth Quarter and Full-Year 2025 Results March 24

TELA Bio

MALVERN, PA — TELA Bio Inc. (NASDAQ: TELA) said it will report financial results for the fourth quarter and full year ended December 31, 2025, on Tuesday, March 24, 2026.

The company said management will host a conference call and webcast at 4:30 p.m. Eastern Time that day to discuss the results and provide a corporate update.

Investors who wish to participate in the call are required to register in advance through the following link: https://edge.media-server.com/mmc/p/sj9anztr.

A live webcast and replay will also be available through the Events & Presentations section of the investor relations page on the company’s website.

READ:  Palvella Therapeutics Launches Awareness Campaign for Rare Lymphatic Disease

TELA Bio is a medical technology company focused on soft-tissue reconstruction products used in surgical procedures.

Additional information about the company is available at https://www.telabio.com.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.